Skip to content
Does Creatine Cause Hair Loss? What the Research Actually Shows
Supplements

Does Creatine Cause Hair Loss? What the Research Actually Shows

Evidence Explainer
9 min read

Does Creatine Cause Hair Loss? What the Research Actually Shows

The claim that creatine causes hair loss has circulated in fitness communities for years, driven by a single 2009 study in rugby players. The short answer: the most current evidence — including a 2025 randomized controlled trial that directly measured hair follicle health — does not support the conclusion that creatine supplementation causes or accelerates hair loss.

Direct Answer: No clinical trial has documented increased hair shedding attributable to creatine. The 2025 RCT (Lak et al., PMID: 40265319) specifically measured hair density, follicular count, and cumulative thickness over 12 weeks and found no differences between creatine and placebo groups. The concern is based on a single outlier study with a within-normal-range DHT elevation that no subsequent study has replicated.


Where Did the Creatine-Hair-Loss Idea Come From?

The concern traces to a 2009 double-blind, placebo-controlled crossover study (van der Merwe et al., PMID: 19741313) involving 20 college-aged male rugby players at a South African rugby institute.

The researchers found that 7 days of creatine loading (25g/day) increased dihydrotestosterone (DHT) by 56%, and the DHT-to-testosterone ratio rose by 36%. After transitioning to a maintenance dose (5g/day) for 14 days, the DHT:T ratio remained elevated by 22%.

This study gained significant attention because DHT is the key androgen in androgenetic alopecia (male pattern hair loss). In men with genetic sensitivity of scalp androgen receptors, higher DHT accelerates follicular miniaturization — progressively shrinking terminal hairs until they stop producing pigmented, thick hair entirely.

The logical chain: creatine increases DHT → DHT causes hair loss → creatine causes hair loss. The problem is that the evidence does not survive scrutiny at each link.


What Does the Full Evidence Say About Creatine and DHT?

The 2009 study is the outlier, not the consensus. Across 12 clinical trials examining creatine’s effects on testosterone and DHT:

  • 10 of 12 trials found no significant change in testosterone or DHT with creatine supplementation
  • Only the 2009 van der Merwe study reported elevated DHT — and in that study, both baseline DHT (0.98 nmol/L) and post-loading DHT (1.26 nmol/L) remained well within the normal physiological range (0.3–3.0 nmol/L for adult males)
  • A 2010 follow-up study by van der Merwe et al. (PMID: 20445368) in a different cohort found no significant change in DHT or DHT:testosterone ratio after creatine supplementation

The 2009 finding may reflect a loading-phase-specific effect using an unusually high dose (25g/day), the specific athlete population studied (rugby players with intensive training protocols that independently elevate androgens), or random variation. The finding has not been replicated.


The 2025 RCT: First Direct Test of Hair Follicle Health

In 2025, researchers published what is the most methodologically rigorous answer to date: a 12-week randomized, double-blind, placebo-controlled trial specifically designed to assess hair follicle health after creatine supplementation (Lak et al., PMID: 40265319).

Study details:

  • Participants: 45 enrolled; 38 completed (resistance-trained men, ages 18–40)
  • Dose: 5g creatine monohydrate daily vs. placebo for 12 weeks
  • Primary outcomes: Hair density, follicular count, cumulative hair thickness (measured using Trichogram test and FotoFinder imaging system)
  • Secondary outcomes: Serum testosterone, free testosterone, DHT

Results: No significant differences between creatine and placebo groups in any measure — testosterone, free testosterone, DHT, hair density, follicular count, or cumulative hair thickness.

The authors concluded this was “the first trial to directly assess hair follicle health following creatine supplementation” and that the results provide “evidence against the claim that creatine contributes to hair loss.”


Understanding DHT and Androgenetic Alopecia: Does the Mechanism Even Support the Concern?

Even accepting the 2009 study’s DHT finding at face value, the causal chain to hair loss requires an additional step: DHT must exceed a threshold in genetically susceptible follicles to cause miniaturization.

Androgenetic alopecia depends critically on androgen receptor sensitivity coded by the AR gene — a highly variable genetic trait. Men without the genetic predisposition for pattern baldness can have elevated DHT for years without experiencing hair loss. DHT-related hair loss is not simply about absolute DHT concentration; it is about genetic receptor sensitivity to DHT at the follicular level.

The DHT elevation in the 2009 study (from 0.98 to 1.26 nmol/L) was modest and within normal range. Even 5-alpha-reductase inhibitors like finasteride — prescription medications that reduce DHT by approximately 70% — do not stop all androgenetic alopecia in all men, precisely because receptor sensitivity is the primary variable, not just serum DHT level.


Does Creatine Affect Testosterone Directly?

The evidence here is clearer: creatine does not meaningfully affect total testosterone. Of 12 trials analyzing creatine’s effects on testosterone, 10 reported no significant change. Creatine works primarily by increasing intramuscular phosphocreatine stores, enabling faster ATP regeneration during high-intensity efforts. It does not act on the hypothalamic-pituitary-gonadal axis or directly stimulate androgen synthesis.


Who Should Take Creatine Despite the Concern?

Creatine monohydrate is one of the most extensively studied and safest sports supplements available. The benefits — increased strength, muscle mass, power output, and emerging evidence for cognitive support — are supported by thousands of studies. The evidence for hair loss risk remains a single non-replicated outlier study with within-range DHT elevations, contradicted by a 2025 RCT that directly measured hair outcomes.

Creatine is appropriate for:

  • Resistance-trained individuals seeking strength and hypertrophy gains
  • Older adults preserving muscle mass and cognitive function (creatine for over-50 adults has emerging evidence for both)
  • Athletes in sports requiring repeated high-intensity efforts

Recommended dose: 3–5g creatine monohydrate daily (no loading phase necessary). Daily consistency matters more than timing.

→ Check Best Creatine Monohydrate Options on Amazon


What If I Have Active Androgenetic Alopecia?

If pattern baldness is already actively progressing, creatine supplementation does not add meaningful risk based on current evidence. The 2025 RCT (PMID: 40265319) recruited resistance-trained men and found no hair follicle changes at the standard maintenance dose over 12 weeks.

However, the 2025 study did not include men with active androgenetic alopecia as a specific subgroup. For men experiencing rapid or aggressive hair loss who are extremely cautious, the most conservative approach is:

  1. Use a maintenance dose of 3–5g/day without a loading phase
  2. Avoid the high loading protocol (25g/day) used in the 2009 study
  3. Monitor hair with standardized photography over 3–6 months

This reflects prudent caution given a gap in direct evidence, not evidence of actual risk.


How We Score: G6 Composite Methodology

Evidence-explainer articles on Body Science Review apply our G6 weighted framework to evaluate the overall evidence quality for a specific claim rather than individual products. For this article, we scored the strength of evidence for and against the creatine-hair-loss hypothesis.

The G6 framework applies these weights (30/25/20/15/10):

  • Research Quality (30%): Strength and volume of human clinical evidence — RCTs, replicated findings, dosing consistency across studies.
  • Evidence Quality (25%): Mechanistic clarity, bioavailability data, and the quality of outcome measures used in trials.
  • Consistency (20%): Degree of agreement across independent research groups; whether findings replicate in different populations.
  • Population Relevance (15%): Whether study populations match the people asking the question (e.g., resistance-trained adults at standard doses).
  • Methodological Transparency (10%): Whether limitations, confounders, and conflicts of interest are clearly disclosed in the literature.

Evidence quality assessment for creatine-hair-loss hypothesis:

CriterionWeightScoreWeighted
Research Quality30%8.52.55
Evidence Quality25%8.02.00
Consistency20%8.51.70
Population Relevance15%7.51.13
Methodological Transparency10%8.00.80
G6 Composite8.2

Score notes: Research Quality earns 8.5 because 11 of 12 clinical trials (including the 2025 dedicated hair follicle RCT) find no effect; the outlier 2009 study had methodological limitations (high loading dose, sports athlete population). Consistency scores 8.5 — overwhelming agreement across studies that standard doses produce no androgen-profile changes. Population Relevance earns 7.5 because most trials used young male athletes rather than diverse populations, leaving a small evidence gap for older adults or those with active androgenetic alopecia.

Overall verdict: The G6 composite evidence score of 8.2/10 against the creatine-hair-loss claim is strong — the evidence base substantially disfavors the hypothesis, with one methodologically limited outlier insufficient to change the assessment.


Practical Guidance: How to Use Creatine to Minimize Any Theoretical Risk

Even setting aside the evidence against a causal link, there are practical choices that minimize any theoretical androgen perturbation:

1. Skip the loading phase. The 2009 study that found elevated DHT used 25g/day for 7 days. Loading phases are not necessary — they simply reach steady-state creatine levels faster. Using a maintenance dose of 3–5g/day from day one avoids the high acute loading dose entirely, with minimal practical difference in time-to-saturate (approximately 3–4 weeks vs. 1 week).

2. Use creatine monohydrate, not alternatives marketed as “less androgenic.” Some supplement companies market creatine HCl or buffered creatine as “gentler” alternatives. There is no evidence these forms produce different androgen profiles. They are simply more expensive forms of creatine with no demonstrated advantage for hair loss concerns.

3. Maintain adequate hydration. Creatine draws water into muscle cells; mild dehydration can concentrate hormones in serum and temporarily alter hormone ratios. Maintaining adequate fluid intake while supplementing creatine eliminates this confounding factor.

4. Monitor with photography if actively concerned. If you have existing androgenetic alopecia and want to monitor while taking creatine, standardized frontal and crown photographs every 4–6 weeks provide objective documentation over a 12-week observation period — the same duration as the 2025 RCT (PMID: 40265319).


The Bottom Line: Current Evidence Does Not Support the Claim

The creatine-hair-loss concern rests entirely on a single 2009 study that:

  • Used an atypically high loading dose
  • Found within-normal-range DHT elevations
  • Has not been replicated in any subsequent trial

The most recent and methodologically rigorous study (PMID: 40265319, 2025) specifically designed to answer this question found zero evidence of hair follicle effects after 12 weeks of creatine supplementation.

Based on the totality of available evidence, creatine supplementation at standard doses (3–5g/day) does not appear to cause or accelerate hair loss in healthy adults.


Frequently Asked Questions

Does creatine cause hair loss?

The current evidence does not support the conclusion that creatine causes hair loss. A 2025 randomized controlled trial (Lak et al., PMID 40265319) directly measured hair follicle density, follicular count, and cumulative thickness after 12 weeks of creatine supplementation and found no significant differences from placebo. The concern originated from a single 2009 study with within-normal-range DHT elevations that has not been replicated.

Does creatine increase DHT levels?

Evidence is conflicting. One 2009 RCT (van der Merwe et al., PMID 19741313) found elevated DHT during a creatine loading phase in rugby players — while remaining within normal physiological range. However, 10 of 12 clinical trials found no significant change in DHT with creatine. The 2025 12-week RCT (PMID 40265319) found no differences in DHT between creatine and placebo groups.

If I am genetically predisposed to hair loss, should I avoid creatine?

Current evidence does not provide sufficient grounds to recommend avoiding creatine based on hair loss concerns, even in genetically predisposed individuals. The only study suggesting a DHT increase used a high-dose loading protocol, and both values stayed within normal range. The 2025 RCT found no measurable hair follicle effects. If you have active androgenetic alopecia and prefer a conservative approach, using a maintenance dose without loading is reasonable.

What creatine dose was used in the studies linking it to hair loss?

The 2009 van der Merwe study (PMID 19741313) used 25g/day for 7 days loading, then 5g/day maintenance. This is higher than standard loading protocols. The 2025 safety study used 5g/day daily without a loading phase — the most common and recommended approach.

What is the best creatine to take if worried about hair loss?

Creatine monohydrate remains the best-evidenced form regardless of hair loss concerns. No evidence suggests alternative creatine forms produce different DHT effects. A maintenance dose of 3–5g/day without a loading phase minimizes any transient androgen perturbation that the 2009 loading protocol might have caused.

Frequently Asked Questions

BS
Researched by Body Science Review Editorial Research Team

Content on Body Science Review is grounded in peer-reviewed evidence from PubMed, Examine.com, and Cochrane reviews, produced to our published editorial standards. See our methodology at /how-we-test.